I-US Food and Drug Administration iphinde ixwayise abathengi ngobungozi obukhulu bomkhiqizo osebenzisa ibhlitjhi njengesithako esiqakathekileko kodwana uthengiselwa njenge "khambi lokulapha koke."
Isikhulumi seendaba se-US Food and Drug Administration (FDA) siphathelene nomkhiqizo obizwa nge-Miracle Mineral Solution (MMS), othengiswa khulu ku-Inthanethi.
Umkhiqizo lo unamagama amanengi afaka hlangana i-Master Mineral Solution, i-Miracle Mineral Supplement, i-Chlorine Dioxide Protocol, kanye ne-Water Purification Solution.
Nanyana i-FDA ingakavumi umkhiqizo lo, abathengisi bawukhangisa njengomuntu olwa namagciwane, amagciwane, kanye namagciwane.
Nanyana kunganalwazi lokurhubhulula kwezokwelapha, abasekeli bathi i-MMS ingalapha kuhle amalwelwe ahlukahlukeneko, okufakahlangana umdlavuza, i-HIV, i-autism, i-acne, imalariya, i-influenza, i-Lyme disease kanye ne-hepatitis.
Umkhiqizo lo uketshezi oluqukethe i-28% ye-sodium chlorite, umkhiqizi ayihlanjululwe ngamanzi wamaminerali. Abathengi kufuze bahlanganise isisombululo ne-citric acid, njengaleyo etholakala kujuzi yelemoni nofana ye-lime.
Ihlanganisela le ihlanganiswa ne-citric acid ukuyenza bona ibe yi-chlorine dioxide. I-FDA iyichaza ngokuthi "yibhlitjhi enamandla." Kuhlekuhle, iindawo zokugaya amaphepha zivame ukusebenzisa i-chlorine dioxide ukuhlanza iphepha, begodu amakhamphani wamanzi nawo asebenzisa ikhemikhali ukuhlanza amanzi wokusela.
I-Ejensi yokuVikela iBhoduluko ye-US (i-EPA) ibeka izinga eliphezulu lama-0.8 wamamiligremu (mg) ngelitha, kodwana ithonsi elilodwa le-MMS line-3-8 mg.
Ukusebenzisa imikhiqizo le kufana nokusebenzisa ibhlitshi. Abathengi akukafaneli basebenzise imikhiqizo le begodu ababelethi akukafaneli bayiphe abantwababo ngaphasi kwananyana ngibuphi ubujamo.
Abantu abathatha i-MMS bafaka imibiko ku-FDA. Umbiko lo ubala irhelo elide lemiphumela emimbi engaba khona, okufakahlangana ukuhlanza okukhulu nokurhuda, umfutho weengazi ophansi obeka engozini ukuphila, nokuhluleka kwesibindi.
Kuyakhathaza ukuthi abanye abakhiqizi be-MMS bathi ukuhlanza nokurhuda ziimpawu ezihle zokuthi ingxube ingaselapha abantu emalwelweni wabo.
U-Dr. Sharpless waragela phambili wathi, "I-FDA izakuragela phambili nokulandela labo abathengisa umkhiqizo oyingozi begodu izokuthatha amagadango afaneleko wokugandelela labo abalinga ukudlula umthetho we-FDA begodu bathengise imikhiqizo engakavunyelwa begodu engaba yingozi emphakathini we-America."
"Into yethu eqakatheke khulu kuvikela umphakathi emikhiqizweni ebeka ingozi epilweni yabo, begodu sizokuthumela umlayezo oqinileko nocacileko wokobana imikhiqizo le ingabanga umonakalo omkhulu."
I-MMS akusiwo umkhiqizo omutjha, sele ikhona emakethe iminyaka engaphezu kwetjhumi. Isazi sezesayensi u-Jim Hamble "wathola" into leyo begodu yayikhuthaza njengekhambi le-autism neminye imiraro.
I-US Food and Drug Administration (FDA) sele ikhuphe isitatimende seendaba malungana nekhemikhali. Isitatimende seendaba sango-2010 saxwayisa ngokuthi, "Abathengi abathathe i-MMS kufanele bayeke ukuyisebenzisa msinyana begodu bayilahle."
Ukuragela phambili kancani, isitatimende seendaba sango-2015 esivela ku-UK Food Standards Agency (FSA) siyelelisa: "Nangabe isisombululo sihlanjululwe ngaphasi kwalokho okutjhiwoko, singabanga umonakalo emathunjini namaseli weengazi abovu begodu nokuhluleka ukuphefumula." I-FSA nayo yeluleka abantu abanemikhiqizo bona "bayilahle."
I-US Food and Drug Administration (FDA) ithe emtlolweni wayo wakamuva weendaba ukuthi nanyana ngubani "ohlangabezana nemiphumela emimbi yepilo ngemva kokudla umkhiqizo lo kufanele afune isizo lezokwelapha msinyana." I-ejensi ibuye ibawa abantu bona babike izehlakalo ezimbi ngehlelo lelwazi lokuphepha le-FDA le-MedWatch.
Ukuhlamba ngebhlitjhi kungehlisa ubungozi bokutheleleka nokuvuvuka ebantwini abane-eczema, kodwana izazi zihlukene ngale ndaba. Akhesicoce ngerhubhululo nokuthi...
Ubulwelwe be-Lyme bulwelwe obudluliselwa ebantwini ngemikhaza enemilenze emnyama. Funda ngeempawu, ukwelatjhwa, nokuthi unganciphisa njani ubungozi bakho.
Amabhathi weqhwa aya ngokuya athandwa khulu hlangana nabathanda ukuzivocavoca, kodwana ingabe aphephile kwamambala? Ingabe kuyazuzisa? Thola bona irhubhululo lithini ngeenzuzo zayo.